Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.77% |
| 2 | Technology | 20.47% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 8.97% |
| 5 | Communication Services | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
776
DELISTED
Acorda Therapeutics
ACOR
| $1.03M | 0.01% |
16,667
+1,065
| +7% | +$80.3K |
|
|
BLUE
777
CALL
DELISTED
bluebird bio
BLUE
| $1.02M | 0.01% |
+1,467
| New | +$1.14M |
|
|
GAP
778
The Gap Inc
GAP
$7.13B
| $1.01M | 0.01% |
+59,123
| New | +$881K |
|
779
Cartesian Therapeutics
RNAC
$304M
| $992K | 0.01% |
13,333
-20,000
| -60% | -$1.53M |
|
|
NAV
780
DELISTED
Navistar International
NAV
| $989K | 0.01% |
22,713
-50,670
| -69% | -$1.74M |
|
|
VIAO
781
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
| $980K | 0.01% |
+110,000
| New | +$1.06M |
|
782
CALL
Cenovus Energy
CVE
$60.7B
| $973K | 0.01% |
+250,000
| New | +$1.15M |
|
|
MRNS
783
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $964K | ﹤0.01% |
+75,000
| New | +$647K |
|
784
JetBlue
JBLU
$1.85B
| $963K | ﹤0.01% |
+85,000
| New | +$954K |
|
785
Adient
ADNT
$1.54B
| $957K | ﹤0.01% |
55,200
-188,514
| -77% | -$3.28M |
|
786
Artisan Partners
APAM
$3B
| $954K | ﹤0.01% |
+24,476
| New | +$897K |
|
787
Texas Capital Bancshares
TCBI
$4.27B
| $937K | ﹤0.01% |
30,100
-16,600
| -36% | -$524K |
|
788
Buckle
BKE
$2.26B
| $936K | ﹤0.01% |
+45,900
| New | +$830K |
|
|
EPAY
789
DELISTED
Bottomline Technologies Inc
EPAY
| $936K | ﹤0.01% |
22,200
+14,500
| +188% | +$688K |
|
790
Rio Tinto
RIO
$171B
| $931K | ﹤0.01% |
+15,420
| New | +$946K |
|
791
TC Energy
TRP
$64.6B
| $924K | ﹤0.01% |
+22,000
| New | +$1.01M |
|
792
Black Hills Corp
BKH
$5.47B
| $904K | ﹤0.01% |
16,903
-9,597
| -36% | -$548K |
|
793
Essent Group
ESNT
$6.12B
| $899K | ﹤0.01% |
24,300
-70,200
| -74% | -$2.51M |
|
794
Stewart Information Services
STC
$2.11B
| $892K | ﹤0.01% |
+20,400
| New | +$824K |
|
795
Americold
COLD
$4.35B
| $887K | ﹤0.01% |
24,800
+19,347
| +355% | +$731K |
|
796
Lamar Advertising Co
LAMR
$15.3B
| $884K | ﹤0.01% |
+13,365
| New | +$888K |
|
|
CIT
797
DELISTED
CIT Group Inc.
CIT
| $862K | ﹤0.01% |
48,673
+41,354
| +565% | +$790K |
|
|
GCP
798
DELISTED
GCP Applied Technologies Inc.
GCP
| $853K | ﹤0.01% |
40,735
+14,272
| +54% | +$330K |
|
799
AerCap
AER
$23B
| $847K | ﹤0.01% |
+33,623
| New | +$974K |
|
|
PLAN
800
DELISTED
Anaplan, Inc.
PLAN
| $844K | ﹤0.01% |
13,492
+10,371
| +332% | +$535K |
|
Similar funds
Steven Cohen's Q3 2020 Portfolio in Review
As of Q3 2020, Steven Cohen held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steven Cohen deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Steven Cohen's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Steven Cohen added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Steven Cohen's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Steven Cohen fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Steven Cohen's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Steven Cohen opened 406 new positions and closed 288 in Q3 2020.
- Steven Cohen's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.